Behavioral and physiological mouse models for anxiety: effects of flesinoxan in 129S6/SvEvTac and C57BL/6J mice
Serotonin 1A (5-HT 1A) receptors are involved in anxiety. This study focuses on the role of genetic factors on the anxiety-related effects of 5-HT 1A receptor stimulation using both a within subject design. The effects of 5-HT 1A receptor activation were studied in high- and low-anxiety mice (129S6/...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2004-06, Vol.494 (1), p.45-53 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Serotonin
1A (5-HT
1A) receptors are involved in anxiety. This study focuses on the role of genetic factors on the anxiety-related effects of 5-HT
1A receptor stimulation using both a within subject design. The effects of 5-HT
1A receptor activation were studied in high- and low-anxiety mice (129S6/SvEvTac (S6) and C57BL/6J (B6), respectively) in behavioral and physiological anxiety-related assays. These two strains were also selected because they are frequently used in gene-targeting studies. Mice were treated with the selective 5-HT
1A receptor agonist flesinoxan (0–0.3–1.0–3.0 mg/kg s.c.) and tested in either the open-field activity test, the light–dark exploration test, or the stress-induced hyperthermia paradigm. Flesinoxan unexpectedly increased anxiety, but also decreased activity on several behavioral measures in B6 mice. Flesinoxan produced only minimal effects in the behavioral tests in the high-anxiety S6 strain. In contrast, the physiological hyperthermia response showed anxiolytic-like effects of flesinoxan in both strains. Our data indicate that the role of 5-HT
1A receptor activation on anxiety-related responses is dependent on genetic background and selected paradigm used to assess anxiety. These findings indicate that it is critical to use a multi-level approach to develop mouse models for human diseases. In addition, the implication of such findings for studies on genetically modified mice is discussed. |
---|---|
ISSN: | 0014-2999 1879-0712 |
DOI: | 10.1016/j.ejphar.2004.04.037 |